SEC Form 4 · accession 0001209191-15-054963
Flexion Therapeutics Inc · FLXN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick J Mahaffy
Director
Period of report
Jun 17, 2015
Accepted (ET)
Jun 19, 2015 · 3:12 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419600
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $21.85 | Jun 17, 2015 | A | 18,000 | A | — | Jun 16, 2025 | Common Stock | 18,000 | 18,000 | D |
Explanation of responses
- F1The stock option vests and becomes exercisable in 12 equal monthly installments following the date of grant.